Pentraxin 3, ischemia-modified albumin, and myeloperoxidase in predicting a cardiac damage in acute carbon monoxide poisoning

Baydın, Ahmet; AMANVERMEZ, Ramazan; Celebi, Huseyin; Tunçel, Özgür; Demircan, Sabri

doi:10.1016/j.ajem.2016.05.043

Pentraxin 3, ischemia-modified albumin, and myeloperoxidase in predicting a cardiac damage in acute carbon monoxide poisoning

Copy For Citation

Baydın A., AMANVERMEZ R., Celebi H. E., Tunçel Ö. K., Demircan S.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, vol.34, no.10, pp.1927-1930, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 34 Issue: 10
Publication Date: 2016
Doi Number: 10.1016/j.ajem.2016.05.043
Journal Name: AMERICAN JOURNAL OF EMERGENCY MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1927-1930
Ondokuz Mayıs University Affiliated: Yes

Abstract

Background: Carbonmonoxide (CO) poisoning is associated with cardiac injuries or manifestations, frequently attributing to direct hypoxic damage at cellular level. For this, the aims were to evaluate the role of serum pentraxin 3 (PTX 3), ischemia-modified albumin (IMA), and myeloperoxidase (MPO) as an early biomarker for cardiac damage when compared to cardiac troponin I (cTnI) and creatine kinase-MB fraction (CK-MB) in adult patients with acute CO poisoning.